Literature DB >> 16238784

Involvement of distal airways in a chronic model of experimental asthma.

M Wegmann1, H Fehrenbach, A Fehrenbach, T Held, C Schramm, H Garn, H Renz.   

Abstract

BACKGROUND: Bronchial asthma is characterized by chronic airway inflammation and airway remodelling which occurs in both proximal and distal airways. These changes are associated with development of airway hyper-responsiveness and airflow limitation.
OBJECTIVE: This study was aimed to analyse whether chronic inhalative allergen challenges in mice lead to morphological and physiological changes comparable with this phenotype.
METHODS: For this purpose, BALB/c mice were systemically sensitized to ovalbumin (OVA) followed by aerosol allergen challenges on 2 consecutive days per week for 12 weeks.
RESULTS: In chronically challenged mice, tissue inflammation in proximal as well as distal airways was observed with a predominance of lymphocytes within the cellular infiltrate. In contrast, inflammation in the airway lumen decreased over time. These changes were associated by a shift in bronchoalveolar lavage-cytokine levels from IL-4, IL-5 and TNF-alpha production (during the acute phase) towards markedly increased levels of TGF-beta during the chronic phase. Goblet cell hyperplasia and subepithelial fibrosis occurred throughout the airway tree. In terms of lung function, chronically challenged mice developed persistent bronchial hyper-responsiveness and progressive airflow limitation. Six weeks after OVA aerosol discontinuation, airway inflammation still persisted although lung function was normalized.
CONCLUSION: These data indicate that our model of chronic aerosol allergen challenges leads to a phenotype of experimental asthma with participation of distal airways and persistence of inflammation thereby resembling many morphological and physiological aspects of human bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16238784     DOI: 10.1111/j.1365-2222.2005.02306.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  23 in total

1.  Glutathione oxidation is associated with airway macrophage functional impairment in children with severe asthma.

Authors:  Anne M Fitzpatrick; W Gerald Teague; Leandrea Burwell; Meredith S Brown; Lou Ann S Brown
Journal:  Pediatr Res       Date:  2011-02       Impact factor: 3.756

2.  Diospyros blancoi attenuates asthmatic effects in a mouse model of airway inflammation.

Authors:  Kyoung-Youl Lee; Ju-Young Jung; Mee-Young Lee; Dayoung Jung; Eun-Sang Cho; Hwa-Young Son
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 3.  Rodent models of allergic rhinitis: relevance to human pathophysiology.

Authors:  James G Wagner; Jack R Harkema
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

4.  Protective effect of emodin against airway inflammation in the ovalbumin-induced mouse model.

Authors:  Tan Wang; Xiang-Gen Zhong; Yu-Hang Li; Xu Jia; Shu-Jing Zhang; Yu-Shan Gao; Miao Liu; Ruo-Han Wu
Journal:  Chin J Integr Med       Date:  2014-12-18       Impact factor: 1.978

5.  Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma.

Authors:  Anne M Fitzpatrick; Lou Ann S Brown; Fernando Holguin; W Gerald Teague
Journal:  J Allergy Clin Immunol       Date:  2009-11       Impact factor: 10.793

Review 6.  T-cell targeted pulmonary siRNA delivery for the treatment of asthma.

Authors:  Tobias W M Keil; Domizia Baldassi; Olivia M Merkel
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-08

7.  Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma.

Authors:  Nicholas Goplen; M Zunayet Karim; Qiaoling Liang; Magdalena M Gorska; Sadee Rozario; Lei Guo; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2009-04       Impact factor: 10.793

Review 8.  Building better mouse models of asthma.

Authors:  Clare M Lloyd
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

9.  Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma.

Authors:  Raffi Tachdjian; Clinton Mathias; Shadi Al Khatib; Paul J Bryce; Hong S Kim; Frank Blaeser; Brian D O'Connor; Danuta Rzymkiewicz; Andrew Chen; Michael J Holtzman; Gurjit K Hershey; Holger Garn; Hani Harb; Harald Renz; Hans C Oettgen; Talal A Chatila
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

10.  Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma.

Authors:  Yuran Xie; Na Hyung Kim; Venkatareddy Nadithe; Dana Schalk; Archana Thakur; Ayşe Kılıç; Lawrence G Lum; David J P Bassett; Olivia M Merkel
Journal:  J Control Release       Date:  2016-03-19       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.